Clinical observations and mechanistic insights of traditional Chinese medicine in the management of diabetic retinopathy

• Published in: Pharmaceutical biology 2024-12, Vol.62 (1), p.529-543
• Main Authors: Chen, Jie, Ni, Yadong, Yao, Wenhui, Ding, Xuansheng
• Format: Article
• Language: English
• Subjects: Animals; blood-retinal barrier; Chinese herb; Chinese medicine; Clinical trials; Diabetes; Diabetes mellitus; Diabetic retinopathy; Diabetic Retinopathy - drug therapy; Disease management; Drugs, Chinese Herbal - pharmacology; Drugs, Chinese Herbal - therapeutic use; Humans; inflammation; Literature reviews; Medicine, Chinese Traditional - methods; neovascularization; neuroprotection; Oxidative stress; Oxidative Stress - drug effects; Retinopathy; Review; Traditional Chinese medicine; Vascularization
• ISSN: 1388-0209; 1744-5116; 1744-5116
• DOI: 10.1080/13880209.2024.2369292

Diabetic retinopathy (DR) is one of the leading causes of vision impairment and blindness among diabetic patients globally. Despite advancements in conventional treatments, the quest for more holistic approaches and fewer side effects persists. Traditional Chinese medicine (TCM) has been used for centuries in managing various diseases, including diabetes and its complications. This review evaluated the efficacy and underlying mechanisms of TCM in the management of DR, providing information on its potential integration with conventional treatment methods. A comprehensive literature review was conducted using PubMed, Web of Science, and the China National Knowledge Infrastructure (CNKI) with the search terms 'traditional Chinese medicine', 'diabetic retinopathy', 'clinical efficacies' and their combinations. Studies published before 2023 without language restriction were included, focusing on clinical trials and observational studies that assessed the effectiveness of TCM in DR treatment. The review synthesized evidence of empirical traditional Chinese formulas, traditional Chinese patent medicines, and isolated phytochemicals on DR treatment. The key mechanisms identified included the reduction of oxidative stress, inflammation, and neovascularization, as well as the improvement in neurovascular functionality and integrity of the retinal blood barrier. TCM shows promising potential to manage DR. More large-scale, randomized controlled trials are recommended to validate these findings and facilitate the integration of TCM into mainstream DR treatment protocols.